Formula Growth’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
10,403
-5,031
-33% -$516K 0.45% 81
2025
Q4
$1.64M Sell
15,434
-11,266
-42% -$1.31M 0.63% 61
2025
Q3
$3.39M Buy
+26,700
New +$3.18M 1.21% 28

Other funds holding EHC

Formula Growth's EHC Position: Q1 2026 in Review

Formula Growth reduced its Encompass Health (EHC) stake by 33% in Q1 2026, selling an estimated $516K and leaving 10,403 shares worth $1.01M. The position accounts for 0.45% of the portfolio, ranked #81.

Formula Growth first reported a position in EHC in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.39M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Formula Growth held 10,403 shares of Encompass Health worth $1.01M as of Q1 2026.
  • Formula Growth sold 5,031 Encompass Health shares in Q1 2026, an estimated $516K.
  • Encompass Health made up 0.45% of Formula Growth's portfolio in Q1 2026, its #81 holding.
  • Formula Growth first reported a position in Encompass Health in Q3 2025 and has held it in 3 quarters since.
  • Formula Growth's Encompass Health position peaked at $3.39M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.